Here's What to Expect From Thermo Fisher Scientific's Next Earnings Report

Valued at a market cap of $159.1 billion, Thermo Fisher Scientific Inc. (TMO) is a global leader in serving science through innovative technologies and services. The company offers life sciences solutions, analytical instruments, specialty diagnostics, laboratory products, and biopharma services worldwide. TMO is slated to announce its fiscal Q2 2025 earnings results before the market opens on Wednesday, Jul. 23. 

Ahead of the event, analysts expect the Waltham, Massachusetts-based company to report an adjusted EPS of $5.22, down 2.8% from $5.37 in the year-ago quarter. However, the company has surpassed Wall Street's bottom-line estimates in the past four quarterly reports. In Q1 2025, Thermo Fisher exceeded the consensus adjusted EPS estimate by nearly 1%.